![](/img/cover-not-exists.png)
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option
Iurlo, Alessandra, Cattaneo, Daniele, Orofino, Nicola, Bucelli, Cristina, Molica, Matteo, Breccia, MassimoLanguage:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-018-0623-7
Date:
January, 2018
File:
PDF, 372 KB
english, 2018